Ryan White Care Hepatitis C & B Language
NATAP Webinar:
Friday 12:30pm ET - October 30th, 2026
Register:
HCV Across the Care Continuum:
From Testing and Treatment to Long-Term Liver Health
Watch Previous NATAP Webinars
Booklet:
ACHIEVING HEALTHY AGING Improving Health Outcomes Over 50
Current HIV Articles and News Updates
HIV
IDWeek:
Potential Drug-Drug Interactions in People Living With HIV on Antiretroviral Therapy Stratified by Age and Sex
- (10/22/26)
IDWeek:
Switching to Islatravir + Ulonivirine Once Weekly Maintained HIV-1 Viral Suppression at Week 24 in the Presence of Baseline Nonnucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations and M184I/V in Proviral DNA
- (10/22/26)
IDWeek:
Exposure-Response Analysis of Islatravir 0.25 mg With Doravirine 100 mg Once Daily in Treatment-Naive and Virologically Suppressed People Living With HIV-1 at Week 48
- (10/22/26)
IDWeek:
FIVE YEARS OF U.S. REAL-WORLD EVIDENCE REINFORCE THE DURABLE EFFECTIVENESS AND LONG-TERM PERSISTENCE OF ViiVHEALTHCARE'S CABENUVA
- (10/22/26)
IDWeek:
Gilead to Present New Data Across HIV and Emerging Antiviral Research at IDWeek 2026
- (10/22/26)
More HIV Articles...
Hepatitis D
HEPATITIS D INFECTION: who should be screened AASLD 2018 HBV Guidelines
144 Weeks of bulevirtide monotherapy for chronic hepatitis D: Final and post-treatment results from a phase III randomized trial
- (08/19/26)
More Hep D Articles...
Aging & Perinatally Acquired HIV
IDWeek:
Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV
- (10/23/26)
IDWeek:
Projected Aging Among People With HIV in the US
- (10/23/26)
IDWeek:
Pharmacokinetic and Clinical Data Supporting the LEN Reloading Strategy for BIC/LEN Single-Tablet Regimen Dosing in the ARTISTRY Studies
- (10/22/26)
IDWeek:
Community HERO Treatment Survey: Characterizing Treatment Journey for Older People with HIV
- (10/22/26)
IDWeek:
Safety Analysis of BIC/LEN Single-Tablet Regimen in People With HIV Who Have Comorbidities of Dyslipidemia, Hypertension, and Diabetes Mellitus From Phase 3 of ARTISTRY-1
- (10/22/26)
IDWeek:
Metabolic and Safety Outcomes With BIC/LEN Single-Tablet Regimen in People With HIV and Comorbidities in ARTISTRY-2
- (10/22/26)
IDWeek:
Efficacy and Safety Outcomes With BIC/LEN Single-Tablet Regimen in People With HIV and Renal Impairment in Phase 3 of ARTISTRY-1
- (10/22/26)
IDWeek:
Week 48 Efficacy and Safety of Doravirine/Islatravir (100 mg/0.25 mg) vs Bictegravir/Emtricitabine/Tenofovir Alafenamide in Previously Untreated Adults Living With HIV-1 With Renal Impairment
- (10/22/26)
IDWeek:
Changes in Fasting Lipids and Insulin Resistance After Switch to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily: Week 96 Results From Two Phase 3 Studies in Adults Living With HIV-1
- (10/22/26)
More Aging & HIV Articles...
PrEP
IDWeek:
Exploring Preferences and Adherence & Persistence among Individuals Initiating PrEP in Portugal: the POSITIVE CARE Study
- (10/22/26)
IDWeek:
Barriers to PrEP, HIV knowledge and perceived stigma among MSM and Heterosexual People Living with HIV in Portugal: the POSITIVE CARE Study
- (10/20/26)
IDWeek:
Baseline Characteristics and Substance Use Among People Who Inject Drugs With Evidence of Active Use in HPTN 103/PURPOSE 4: A Phase 2 Study of Twice-Yearly Subcutaneous Lenacapavir for Pre-Exposure Prophylaxi
- (10/20/26)
More PreP Articles...
Current Hepatitis C and B Articles
Hepatitis C
Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy; Commentary: Treatment of Hepatitis C During Pregnancy: We Are Approaching a "Tipping Point"
- (10/13/26)
Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019-2023: A Retrospective Cohort Study
- (10/07/26)
Glecaprevir/Pibrentasvir Concentrations in the Breastmilk of Lactating Women
- (10/07/26)
More Hep C Articles...
Hepatitis B
HBV Patient Declaration of Rights
-
Brief Report: Hepatitis B Vaccination Histories in Persons With HIV Needing Revaccination
- (08/14/26)
IAS
Evaluation of hepatitis B virus epidemiology and impact of select demographic factors on seroprevalence within an urban clinic in the US
- (08/02/26)
More Hep B Articles...
Fatty Liver, NAFLD, NASH, MASLD, MASH
PREVALENCE AND SEVERITY OF STEATOTIC LIVER DISEASE IN WOMEN WITH AND WITHOUT HIV
- (10/12/26)
Risk of Hepatocellular Carcinoma or Hepatic Decompensation Associated with Steatotic Liver Disease in People with and without HIV
- (10/07/26)
Recompensation of decompensated cirrhosis in a spectrum of metabolic dysfunction-related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors
- (10/02/26)
Metabolic dysfunction-associated steatotic liver disease in people living with HIV: a framework for integrated screening and care
- (09/16/26)
Sex-Specific Cardiometabolic Profiles and Severity of Liver Fibrosis
- (08/26/26)
More Fatty Liver Articles...
Check Out Our Special NATAP Features
List not necessarily listed here in order of date being held.
Conference List Here
https://www.croiconference.org/
https://academicmedicaleducation.com/programs/3rd-african-workshop-on-women-and-hiv-2026
https://academicmedicaleducation.com/programs/16th-international-workshop-on-women-and-hiv-2026
https://acthiv.org/
https://ddw.org/?doing_wp_cron=1768748258.8390960693359375000000
https://www.easlcongress.eu/
https://asm.org/events/asm-microbe/home
https://academicmedicaleducation.com/programs/24th-european-meeting-on-hiv-and-hepatitis-2026
https://www.iasociety.org/conferences/aids2026
https://academicmedicaleducation.com/programs?page=2
https://academicmedicaleducation.com/programs/27th-international-workshop-on-clinical-pharmacology-of-hiv-hepatitis-and-other-antiviral-drugs-2026
2026 U.S. Conference on HIV/AIDS
Register to join us from September 17-20, 2026 in Anaheim, CA
Theme - United and Unbreakable: The HIV Movement at 45
https://www.nmac.org/uscha/
https://academicmedicaleducation.com/programs/9th-conference-on-liver-disease-in-africa-colda-2026
https://academicmedicaleducation.com/programs/17th-international-workshop-on-aging-and-hiv-2026
https://idweek.org/
https://aasld-igh.org/Home.aspx https://www.aasld.org/the-liver-meeting
https://hivglasgow.org/
